Equities

Dalian BIO-CHEM Co Ltd

603360:SHH

Dalian BIO-CHEM Co Ltd

Actions
Basic MaterialsChemicals
  • Price (CNY)22.86
  • Today's Change-2.54 / -10.00%
  • Shares traded26.77m
  • 1 Year change+174.95%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments534396213
Total Receivables, Net405411215
Total Inventory207181187
Prepaid expenses564031
Other current assets, total662282
Total current assets1,2671,050728
Property, plant & equipment, net625635832
Goodwill, net------
Intangibles, net424392
Long term investments7.52140.67
Note receivable - long term------
Other long term assets------
Total assets1,9421,7541,671
LIABILITIES
Accounts payable4767138
Accrued expenses161815
Notes payable/short-term debt179129342
Current portion long-term debt/capital leases0.40----
Other current liabilities, total272742
Total current liabilities270241537
Total long term debt0.3800
Total debt180129342
Deferred income tax254237
Minority interest--0--
Other liabilities, total9.341147
Total liabilities305293621
SHAREHOLDERS EQUITY
Common stock360259261
Additional paid-in capital79130140
Retained earnings (accumulated deficit)1,2141,190787
Treasury stock - common(11)(118)(139)
Unrealized gain (loss)(5.84)----
Other equity, total0.170.170.15
Total equity1,6371,4611,050
Total liabilities & shareholders' equity1,9421,7541,671
Total common shares outstanding500487496
Treasury shares - common primary issue4.592016
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.